Oppenheimer Remains a Hold on Intuitive Surgical (ISRG)


Oppenheimer analyst Suraj Kalia maintained a Hold rating on Intuitive Surgical (ISRG) today. The company’s shares closed last Monday at $613.08, close to its 52-week high of $619.00.

According to TipRanks.com, Kalia is a 4-star analyst with an average return of 5.6% and a 53.0% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Edwards Lifesciences.

Intuitive Surgical has an analyst consensus of Strong Buy, with a price target consensus of $668.67.

See today’s analyst top recommended stocks >>

Intuitive Surgical’s market cap is currently $71.11B and has a P/E ratio of 53.10. The company has a Price to Book ratio of 8.61.

Based on the recent corporate insider activity of 64 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ISRG in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Read More on ISRG:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts